WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 18.08.2018 at 9:00 AM CEST
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017057743) TRANSDERMALLY ABSORBABLE COMPOSITION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/057743 International Application No.: PCT/JP2016/079149
Publication Date: 06.04.2017 International Filing Date: 30.09.2016
IPC:
A61K 31/568 (2006.01) ,A61K 47/10 (2017.01) ,A61K 47/32 (2006.01) ,A61K 47/34 (2017.01) ,A61P 5/24 (2006.01)
Applicants: FUJIFILM CORPORATION[JP/JP]; 26-30, Nishiazabu 2-chome, Minato-ku, Tokyo 1068620, JP
Inventors: SONOKE, Shirou; JP
IZUMI, Yasuyuki; JP
YAMAZAKI, Naomi; JP
Agent: NAKAJIMA, Jun; JP
KATO, Kazuyoshi; JP
FUKUDA, Koji; JP
Priority Data:
2015-19435430.09.2015JP
2016-13969014.07.2016JP
Title (EN) TRANSDERMALLY ABSORBABLE COMPOSITION
(FR) COMPOSITION ABSORBABLE PAR VOIE TRANSDERMIQUE
(JA) 経皮吸収用組成物
Abstract:
(EN) Provided is a transdermally absorbable composition that contains testosterone, and one or more organic solvents selected from the group consisting of propylene glycol, 1,3-butylene glycol, dipropylene glycol and polyethylene glycol, wherein the total content of the organic solvents is 60% by mass to 90% by mass of the whole amount of the transdermally absorbable composition, and the content of C2-4 monohydric alcohol is 10% by mass or less of the whole amount of the transdermally absorbable composition.
(FR) L'invention concerne une composition absorbable par voie transdermique, qui contient de la testostérone et un ou plusieurs solvants organiques choisis dans le groupe constitué par propylène glycol, 1,3-butylène glycol, dipropylène glycol et polyéthylène glycol, la teneur totale en solvants organiques représentant 60 % en masse à 90 % en masse de la quantité totale de la composition absorbable par voie transdermique, et la teneur en alcool monohydrique C2-4 représentant 10 % en masse ou moins de la quantité totale de la composition absorbable par voie transdermique.
(JA) テストステロンと、プロピレングリコール、1,3-ブチレングリコール、ジプロピレングリコール及びポリエチレングリコールからなる群より選ばれる1種以上の有機溶媒と、を含み、有機溶媒の総含有量が、経皮吸収用組成物の全量に対し60質量%~90質量%であり、かつ、炭素数2~4の一価アルコールの含有量が経皮吸収用組成物の全量に対し10質量%以下である経皮吸収用組成物。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)